ApicHope Pharmaceutical Co., Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 903.71 million compared to CNY 953.02 million a year ago. Revenue was CNY 905.11 million compared to CNY 953.18 million a year ago.

Net income was CNY 154.6 million compared to CNY 117.96 million a year ago. Basic earnings per share from continuing operations was CNY 0.3577 compared to CNY 0.2729 a year ago. Diluted earnings per share from continuing operations was CNY 0.3577 compared to CNY 0.2729 a year ago.